Company page
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. Class A, trading under the ticker 002399, is a public company based in China. The company has a market capitalization of approximately $1.73 billion. Hepalink specializes in the pharmaceutical industry, focusing on the development and production of heparin and other related products.
- Ticker
- 002399:SZSE
- Asset type
- Stock
- Market cap
- $1.73B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- SZSE
- Currency
- CNY